Health Trials

Chemotherapy, Adjuvant

2

Review clinical trials related to Chemotherapy, Adjuvant. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.

The goal of this randomized clinical trial is to investigate whether pressurized intraperitoneal chemotherapy (PIPAC), delivered immediately after minimally invasive D2 gastrectomy and repeated 6-8 weeks later, improves 12-month peritoneal disease-free survival in patients with high-risk gastric adenocarcinoma when compared to standard treatment.

Participants needed: 264
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Odense University HospitalUpdated: Mar 6, 2024Locations: 5
Eligibility criteria

Gastric or Gastroesophageal junction Siewert type III adenocarcinomas [+12]

Previous allergic reaction to cisplatin, doxorubicin or other platinum-containin... [+5]

Read more
Status: Recruiting

Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%

Randomized phase II trial aims to compare surgery with or without adjuvant chemotherapy in treating patients who are pathologically diagnosed as stage I lung adenocarcinoma with micropapillary component no less than 20%.

Participants needed: 460
Trial details
Phase: Phase 2Age: 19-70Biological sex: AllType: InterventionalSponsor: Shanghai Pulmonary Hospital, Shanghai, ChinaUpdated: Dec 19, 2017Locations: 1
Eligibility criteria

Completely resected Stage I NSCLC as defined by the International Staging System [+10]

Do not meet the inclusion criteria [+10]

Read more